Cargando…

Relationship between Dasatinib-induced Pulmonary Hypertension and Drug Dose

OBJECTIVE: Dasatinib, a second-generation tyrosine kinase inhibitor, is used for chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It reportedly causes pulmonary arterial hypertension (PAH) and the dose-dependent induction of apoptosis in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kubota, Kana, Imai, Yasushi, Oh, Iekuni, Ueno, Shuichi, Kanda, Yoshinobu, Kario, Kazuomi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424090/ https://www.ncbi.nlm.nih.gov/pubmed/35022343 http://dx.doi.org/10.2169/internalmedicine.8392-21

Ejemplares similares

Imatinib dramatically alleviates pulmonary tumour thrombotic microangiopathy induced by gastric cancer
por: Kubota, Kana, et al.
Publicado: (2017)

Dasatinib-induced Pulmonary Hypertension
por: Tamura, Yudai, et al.
Publicado: (2022)

Syncope after COVID-19 Vaccination in a Young Man with Unmasking Brugada Syndrome
por: Okuyama, Takafumi, et al.
Publicado: (2023)

Association of lower nighttime diastolic blood pressure and hypoxia with silent myocardial injury: The Japan Morning Surge‐Home Blood Pressure study
por: Kubota, Kana, et al.
Publicado: (2020)

Key Points of the 2019 Japanese Society of Hypertension Guidelines for the Management of Hypertension
por: Kario, Kazuomi
Publicado: (2019)

Pulmonary hypertension with dasatinib and other tyrosine kinase inhibitors
por: El-Dabh, Ashraf, et al.
Publicado: (2019)

Association between P wave polarity in atrial premature complexes and cardiovascular events in a community-dwelling population
por: Kabutoya, Tomoyuki, et al.
Publicado: (2020)

Combination targeted pulmonary hypertension therapy in the resolution of Dasatinib-associated pulmonary arterial hypertension
por: Jose, Arun, et al.
Publicado: (2017)

Reversible Pulmonary Arterial Hypertension Associated with Dasatinib for Chronic Myeloid Leukemia
por: Hong, Ji Hyung, et al.
Publicado: (2015)

Sleep and nocturnal hypertension: Genes, environment, and individual profiles
por: Kario, Kazuomi
Publicado: (2022)

Plasma concentrations of dasatinib have a clinical impact on the frequency of dasatinib dose reduction and interruption in chronic myeloid leukemia: an analysis of the DARIA 01 study
por: Mizuta, Shuichi, et al.
Publicado: (2018)

Successful transvenous implantable cardioverter-defibrillator implantation supported by preceding 3D electro-anatomical mapping for a ventricular fibrillation survivor with surgically repaired congenitally corrected transposition of the great arteries: a case report
por: Mitama, Tadayuki, et al.
Publicado: (2022)

Management of Hypertension in the Digital Era: Small Wearable Monitoring Devices for Remote Blood Pressure Monitoring
por: Kario, Kazuomi
Publicado: (2020)

Dasatinib-Induced Pulmonary Arterial Hypertension Treated with Upfront Combination Therapy
por: Nishimori, Makoto, et al.
Publicado: (2018)

Rho-Kinase Inhibition Ameliorates Dasatinib-Induced Endothelial Dysfunction and Pulmonary Hypertension
por: Fazakas, Csilla, et al.
Publicado: (2018)

Pulmonary arterial hypertension in a patient treated with dasatinib: a case report
por: Skride, Andris, et al.
Publicado: (2017)

Dasatinib-induced pulmonary arterial hypertension complicated with scleroderma: a case report
por: Toya, Takumi, et al.
Publicado: (2019)

Melatonin Attenuates Dasatinib-Aggravated Hypoxic Pulmonary Hypertension via Inhibiting Pulmonary Vascular Remodeling
por: Wang, Rui, et al.
Publicado: (2022)

Low-dose Dasatinib Ameliorates Hypertrophic Cardiomyopathy in Noonan Syndrome with Multiple Lentigines
por: Yi, Jae-Sung, et al.
Publicado: (2021)

Sympathetic modulation by antihypertensive drugs
por: Katsurada, Kenichi, et al.
Publicado: (2021)

Digital Hypertension 2023: Concept, hypothesis, and new technology
por: Kario, Kazuomi, et al.
Publicado: (2022)

Differences in ambulatory blood pressure profiles between Japanese and Thai patients with hypertension /suspected hypertension
por: Tomitani, Naoko, et al.
Publicado: (2020)

Systolic hypertension: an increasing clinical challenge in Asia
por: Park, Jeong Bae, et al.
Publicado: (2015)

Cost-effectiveness of digital therapeutics for essential hypertension
por: Nomura, Akihiro, et al.
Publicado: (2022)

Efficacy and Tolerability after Unusually Low Doses of Dasatinib in Chronic Myeloid Leukemia Patients Intolerant to Standard-Dose Dasatinib Therapy
por: Serpa, Mariana, et al.
Publicado: (2010)

The first software as medical device of evidence-based hypertension digital therapeutics for clinical practice
por: Kario, Kazuomi, et al.
Publicado: (2022)

Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension?
por: Hennigs, Jan K, et al.
Publicado: (2011)

Variables associated with pulmonary hypertension screened by echocardiography in chronic myeloid leukemia patients on dasatinib therapy
por: Jin, Wenying, et al.
Publicado: (2022)

A narrative review on adverse effects of dasatinib with a focus on pharmacotherapy of dasatinib-induced pulmonary toxicities
por: Nekoukar, Zahra, et al.
Publicado: (2021)

Titration of amlodipine to higher doses: a comparison of Asian and Western experience
por: Kario, Kazuomi, et al.
Publicado: (2013)

Dasatinib dose management for the treatment of chronic myeloid leukemia
por: Talpaz, Moshe, et al.
Publicado: (2018)

The HOPE Asia Network activity 2022: Towards better hypertension management in Asia
por: Kario, Kazuomi, et al.
Publicado: (2022)

Anti-hypertensive medication adherence in the REQUIRE trial: post-hoc exploratory evaluation
por: Kario, Kazuomi, et al.
Publicado: (2023)

Cardiovascular Disease Prevention in Patients With Atherosclerotic Renovascular Disease‐Induced Resistant Hypertension: Further Considerations for 24‐Hour Blood Pressure Profiles
por: Narita, Keisuke, et al.
Publicado: (2022)

Change of right ventricular systolic pressure can indicate dasatinib‐induced pulmonary arterial hypertension in chronic myeloid leukemia
por: Lee, Sung‐Eun, et al.
Publicado: (2021)

A case of worsening pulmonary arterial hypertension and pleural effusions by bosutinib after prior treatment with dasatinib
por: Seegobin, Karan, et al.
Publicado: (2017)

Leadless Pacemaker Implantation for a Super-elderly Woman with a Mediastinal Tumor
por: Kabutoya, Tomoyuki, et al.
Publicado: (2021)

Progression from prehypertension to hypertension and risk of cardiovascular disease
por: Ishikawa, Yukiko, et al.
Publicado: (2016)

A Suspected Case of an Alveolar Haemorrhage Caused by Dasatinib
por: Sakoda, Yoritake, et al.
Publicado: (2017)

New dosing schedules of dasatinib for CML and adverse event management
por: Wong, Siu-Fun
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_2m75qr5ohhr1rpv6v6f5b3hb7k